Genetic Analysis of Second Messengers in PTH Signaling in Bone
Genetic Analysis of Second Messengers in PTH Signaling in Bone
批准号:
7627067
负责人:
HENRY M. KRONENBERG
金额:
$39.62万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-12-01 至 2013-11-30
关键词:
AffectAgeAnabolic AgentsApoptosisApoptoticBirthBone ResorptionCalciumCell SurvivalCellsDEXADataDevelopmentDietDiseaseDissectionDoxycyclineExcisionFibroblast Growth FactorFlow CytometryFractureGene ExpressionGenerationsGenesGenetic ModelsGoalsHeterotrimeric GTP-Binding ProteinsHormonalIn Situ HybridizationIn VitroInfusion proceduresInjection of therapeutic agentKidneyKnock-in MouseKnock-outLinkMeasurementMediatingMediator of activation proteinModelingMolecularMusMutateOrganOsteoblastsOsteoclastsOsteocytesOsteogenesisOsteoporosisParathyroid Hormone ReceptorPartner in relationshipPathway interactionsPhospholipase CPhysiologyReceptor ActivationRoleSecond Messenger SystemsSerologicalSignal TransductionStagingStromal CellsSumTRANCE proteinTetanus Helper PeptideTetracyclinesTimeWithdrawalbonebone masscalcium metabolismgenetic analysisin vivoin vivo Modelmutantosteoblast differentiationparathyroid hormone-related proteinpromoterreceptorrecombinaseresponsesecond messenger
中文摘要
了解甲状旁腺激素对骨的合成代谢作用的机制很重要,因为甲状旁腺激素
英文摘要
Understanding the mechanisms of the anabolic action of PTH on bone is important both because PTH
represents the first anabolic agent useful to treat osteoporosis and because a molecular understanding of
PTH's anabolic action will allow the development of even more effective anabolic agents. Our goal here is to
use in vivo models to establish the roles of specific "second messenger" pathways responsible for the
various actions of PTH that, in sum, result in an increase in bone mass. Understanding of the multiple,
specific pathways leading in varying ways to increased bone will make possible the next rational generation
of anabolic agents. We also want to understand these mechanisms to understand better the roles of PTH
and PTHrP in normal physiology and disease. PTH and PTHrP stimulate both bone formation and bone
resorption through activation of the PTH/PTHrP receptor (PTHR1) in cells of the osteoblast lineage. The
PTHR1 activates several heterotrimeric G proteins, with Gs and Gq/11 being the best characterized. We will
use two genetic models that allow the separation of the actions of these downstream mediators in vivo. One
model uses a "knock-in" mouse in which the normal PTHR1 gene has been mutated to selectively disrupt the
activation of phospholipase C by the Gq/11 pathway without affecting activation of Gs. The other model is a
conditional knockout in which the osterix promoter, active in early osteoblasts, drives the expression of ere
recombinase in a way that can be suppressed by tetracycline derivatives ("tet-off"). This ere is used to
ablate expression of Gsa postnatally in early cells of the osteoblast lineage through mating with a Gsa floxed
mouse and administration of doxycycline for various times. Three models of receptor activation (continuous
elevation of PTH through minipump infusion or low calcium diet, and once daily injection of PTH) will be used
to determine the roles of distinct pathways in the variety of actions of the PTHR1 on cells of the osteoblast
lineage. Aim 1. Role of PLC signaling in actions of the PTHR1 in bone. Models of intermittent and
continuous PTH administration will be used to determine the role of PTHR1 activation of PLC in bone.Aim 2.
Role of Gs signaling in cells of the osteoblast lineage. Comparison of mice missing Gsa in osteoblastic cells
with the same mice exposed to continuous or intermittent elevation of PTH levels should allow identification
of the responses to activation of the PTHR1 that require Gsalpha
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of osteoblast progenitors in response to bone anabolic agents
-
批准号:10404415
-
项目类别:
-
资助金额:$92.4万
-
财政年份:2023
-
负责人:HENRY M. KRONENBERG
-
依托单位:
PTH actions on early cells of the osteoblast lineage
-
批准号:10207597
-
项目类别:
-
资助金额:$40.85万
-
财政年份:2020
-
负责人:HENRY M. KRONENBERG
-
依托单位:
Administrative Core
-
批准号:10451721
-
项目类别:
-
资助金额:$31.87万
-
财政年份:2019
-
负责人:HENRY M. KRONENBERG
-
依托单位:
Administrative Core
-
批准号:10183170
-
项目类别:
-
资助金额:$31.87万
-
财政年份:2019
-
负责人:HENRY M. KRONENBERG
-
依托单位:
Administrative Core
-
批准号:10626807
-
项目类别:
-
资助金额:$31.87万
-
财政年份:2019
-
负责人:HENRY M. KRONENBERG
-
依托单位:
CENTER FOR SKELETAL RESEARCH
-
批准号:9285601
-
项目类别:
-
资助金额:$69.6万
-
财政年份:2014
-
负责人:HENRY M. KRONENBERG
-
依托单位:
CENTER FOR SKELETAL RESEARCH
-
批准号:8853820
-
项目类别:
-
资助金额:$69.6万
-
财政年份:2014
-
负责人:HENRY M. KRONENBERG
-
依托单位:
CENTER FOR SKELETAL RESEARCH
-
批准号:8693238
-
项目类别:
-
资助金额:$69.6万
-
财政年份:2014
-
负责人:HENRY M. KRONENBERG
-
依托单位:
Functions of PTH/PHTrP Receptor, PTHrP and PTH in vivo
-
批准号:7432428
-
项目类别:
-
资助金额:$39.9万
-
财政年份:2007
-
负责人:HENRY M. KRONENBERG
-
依托单位:
Role of PLC in PTH Signaling: Mutant Receptors in Vivo
-
批准号:7325709
-
项目类别:
-
资助金额:$30.68万
-
财政年份:2006
-
负责人:HENRY M. KRONENBERG
-
依托单位:
2007 CARTILAGE BIOLOGY & PATHOLOGY GORDON RESEARCH CONFERENCE
-
批准号:7218758
-
项目类别:
-
资助金额:$1.2万
-
财政年份:2006
-
负责人:HENRY M. KRONENBERG
-
依托单位:
2007 CARTILAGE BIOLOGY & PATHOLOGY GORDON RESEARCH CONFERENCE
-
批准号:7386300
-
项目类别:
-
资助金额:$0.3万
-
财政年份:2006
-
负责人:HENRY M. KRONENBERG
-
依托单位:
Specialized Center for Cell Based Therapy
-
批准号:7126374
-
项目类别:
-
资助金额:$210.08万
-
财政年份:2005
-
负责人:HENRY M. KRONENBERG
-
依托单位:
Functions of PTH/PHTrP Receptor, PTHrP and PTH in vivo
-
批准号:6946563
-
项目类别:
-
资助金额:$41.35万
-
财政年份:2005
-
负责人:HENRY M. KRONENBERG
-
依托单位:
Specialized Center for Cell Based Therapy
-
批准号:7690371
-
项目类别:
-
资助金额:$230.0万
-
财政年份:2005
-
负责人:HENRY M. KRONENBERG
-
依托单位:
Role of PLC in PTH Signaling: Mutant Receptors in Vivo
-
批准号:7160506
-
项目类别:
-
资助金额:$30.78万
-
财政年份:2005
-
负责人:HENRY M. KRONENBERG
-
依托单位:
Specialized Center for Cell Based Therapy
-
批准号:7282059
-
项目类别:
-
资助金额:$218.94万
-
财政年份:2005
-
负责人:HENRY M. KRONENBERG
-
依托单位:
Role of PLC in PTH Signaling: Mutant Receptors in Vivo
-
批准号:7062733
-
项目类别:
-
资助金额:$31.54万
-
财政年份:2004
-
负责人:HENRY M. KRONENBERG
-
依托单位:
Role of PLC in PTH Signaling: Mutant Receptors in Vivo
-
批准号:6744652
-
项目类别:
-
资助金额:$31.84万
-
财政年份:2003
-
负责人:HENRY M. KRONENBERG
-
依托单位:
OSTEOBLAST SPECIFIC ABLATION OF THE PTH/PTHRP RECEPTOR
-
批准号:6660896
-
项目类别:
-
资助金额:$28.21万
-
财政年份:2002
-
负责人:HENRY M. KRONENBERG
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: